Page last updated: 2024-08-26

lambertianic acid and Lung Neoplasms

lambertianic acid has been researched along with Lung Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahn, DS; Han, H; Hwang, J; Kim, B; Kim, SH; Lee, HJ; Shim, B	1

Other Studies

1 other study(ies) available for lambertianic acid and Lung Neoplasms

Article	Year
Lambertianic Acid Sensitizes Non-Small Cell Lung Cancers to TRAIL-Induced Apoptosis via Inhibition of XIAP/NF-κB and Activation of Caspases and Death Receptor 4. International journal of molecular sciences, 2018, May-16, Volume: 19, Issue:5 Topics: Apoptosis; Biomarkers; Carboxylic Acids; Carcinoma, Non-Small-Cell Lung; Caspases; Cell Cycle; Cell Line, Tumor; Humans; Lung Neoplasms; Naphthalenes; NF-kappa B; Receptors, TNF-Related Apoptosis-Inducing Ligand; TNF-Related Apoptosis-Inducing Ligand; X-Linked Inhibitor of Apoptosis Protein	2018

Article

Year

Lambertianic Acid Sensitizes Non-Small Cell Lung Cancers to TRAIL-Induced Apoptosis via Inhibition of XIAP/NF-κB and Activation of Caspases and Death Receptor 4.

International journal of molecular sciences, 2018, May-16, Volume: 19, Issue:5

Topics: Apoptosis; Biomarkers; Carboxylic Acids; Carcinoma, Non-Small-Cell Lung; Caspases; Cell Cycle; Cell Line, Tumor; Humans; Lung Neoplasms; Naphthalenes; NF-kappa B; Receptors, TNF-Related Apoptosis-Inducing Ligand; TNF-Related Apoptosis-Inducing Ligand; X-Linked Inhibitor of Apoptosis Protein

2018